Juliana Camacho-Pereira
Overview
Explore the profile of Juliana Camacho-Pereira including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
663
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Camacho-Pereira J, Lai de Souza L, Chichierchio M, Rodrigues-Chaves C, Lomba L, Fonseca-Oliveira M, et al.
Free Radic Biol Med
. 2023 Sep;
209(Pt 1):29-39.
PMID: 37774804
Aging is a time-related functional decline that affects many species. One of the hallmarks of aging is mitochondrial dysfunction, which leads to metabolic decline. The NAD decline during aging, in...
2.
Santos L, Benitez-Rosendo A, Bresque M, Camacho-Pereira J, Calliari A, Escande C
Antioxid Redox Signal
. 2023 Sep;
39(16-18):1185-1208.
PMID: 37767625
Sirtuins are NAD-dependent histone deacetylases regulating important processes in cellular biology such as inflammation, metabolism, oxidative stress, and apoptosis. Despite initially being discovered to regulate transcription and life span histone...
3.
Cal K, Leyva A, Rodriguez-Duarte J, Ruiz S, Santos L, Colella L, et al.
Res Sq
. 2023 Jul;
PMID: 37502859
Obesity-related type II diabetes (diabesity) has increased global morbidity and mortality dramatically. Previously, the ancient drug salicylate demonstrated promise for the treatment of type II diabetes, but its clinical use...
4.
Formiga-Jr M, Camacho-Pereira J
J Vis Exp
. 2022 May;
(183).
PMID: 35604137
Mitochondrial dysfunction in peripheral nerves accompanies several diseases associated with peripheral neuropathy, which can be triggered by multiple causes, including autoimmune diseases, diabetes, infections, inherited disorders, and tumors. Assessing mitochondrial...
5.
Martins E, Ricardo J, de-Souza-Ferreira E, Camacho-Pereira J, Ramos-Filho D, Galina A
Comp Biochem Physiol B Biochem Mol Biol
. 2017 Dec;
217:40-50.
PMID: 29222029
Different exercise protocols lead to long-term adaptations that are related to increased mitochondrial content through the activation of mitochondrial biogenesis. However, immediate mitochondrial response to exercise and energetic substrate utilization...
6.
Camacho-Pereira J, Tarrago M, Chini C, Nin V, Escande C, Warner G, et al.
Cell Metab
. 2016 Jun;
23(6):1127-1139.
PMID: 27304511
Nicotinamide adenine dinucleotide (NAD) levels decrease during aging and are involved in age-related metabolic decline. To date, the mechanism responsible for the age-related reduction in NAD has not been elucidated....
7.
Mondal S, Roy D, Camacho-Pereira J, Khurana A, Chini E, Yang L, et al.
Oncotarget
. 2015 Sep;
6(32):33705-19.
PMID: 26378042
Warburg effect has emerged as a potential hallmark of many cancers. However, the molecular mechanisms that led to this metabolic state of aerobic glycolysis, particularly in ovarian cancer (OVCA) have...
8.
Wang Y, Cao Y, Yamada S, Thirunavukkarasu M, Nin V, Joshi M, et al.
Arterioscler Thromb Vasc Biol
. 2015 Apr;
35(6):1401-12.
PMID: 25882068
Objective: Neuropilin-1 (NRP-1) is a multidomain membrane receptor involved in angiogenesis and development of neuronal circuits, however, the role of NRP-1 in cardiovascular pathophysiology remains elusive. Approach And Results: In...
9.
Chini C, Gonzalez Guerrico A, Nin V, Camacho-Pereira J, Escande C, Barbosa M, et al.
Clin Cancer Res
. 2013 Sep;
20(1):120-30.
PMID: 24025713
Purpose: Here, we describe a novel interplay between NAD synthesis and degradation involved in pancreatic tumor growth. Experimental Design: We used human pancreatic cancer cells, both in vitro (cell culture...
10.
da Silva M, Mattos E, Camacho-Pereira J, Domitrovic T, Galina A, Costa M, et al.
Exp Clin Cardiol
. 2013 Apr;
17(3):101-9.
PMID: 23620696
Doxorubicin (DOXO) is an efficient and low-cost chemotherapeutic agent. The use of DOXO is limited by its side effects, including cardiotoxicity, that may progress to cardiac failure as a result...